tradingkey.logo
tradingkey.logo
Pesquisar

Oncology Institute Inc

TOI
Adicionar à lista de desejos
5.280USD
-0.230-4.17%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
522.00MValor de mercado
PerdaP/L TTM

Mais detalhes de Oncology Institute Inc Empresa

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Informações de Oncology Institute Inc

Código da empresaTOI
Nome da EmpresaOncology Institute Inc
Data de listagemMar 13, 2020
CEOVirnich (Daniel)
Número de funcionários825
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 13
Endereço18000 Studebaker Rd
CidadeCERRITOS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal90703
Telefone15627353226
Sitehttps://theoncologyinstitute.com/
Código da empresaTOI
Data de listagemMar 13, 2020
CEOVirnich (Daniel)

Executivos da empresa Oncology Institute Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Oncology Institute Inc?

Os cinco principais acionistas de Oncology Institute Inc são: Dr. Daniel Virnich, M.D.

Quantas instituições possuem ações da Oncology Institute Inc (TOI)?

Em 2026Q1, 204 instituições possuíam ações da Oncology Institute Inc, com valor de mercado aproximado de 47.47M, representando 47.57% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -10136464.00.

Qual é a maior fonte de receita da Oncology Institute Inc?

Em 2026Q1, o segmento de negócios Dispensary revenue gerou a maior receita para Oncology Institute Inc, totalizando 269.18M e representando 53.54% da receita total.